TMP-301 / Nxera Pharma, Tempero Bio  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TMP-301 / Tempero Bio
NCT03785054: Phase 1, Healthy Subject, Safety, Tolerability and Pharmacokinetic Study of mGlu5 NAM HTL0014242

Completed
1
71
Europe
HTL0014242, Placebo oral capsule
Heptares Therapeutics Limited, Covance
Healthy
03/21
03/21
NCT04462263: Study to Investigate the Receptor Occupancy of HTL0014242 Using [18F] FPEB in Healthy Male Subjects

Completed
1
8
Europe
HTL0014242
Heptares Therapeutics Limited
Healthy
06/21
06/21
NCT06025396: Multiple Ascending Dose Study of TMP-301 in Healthy Subjects

Completed
1
30
US
TMP-301, Placebo
Tempero Bio, Inc., National Institute on Drug Abuse (NIDA)
Cocaine Use Disorder, Substance Use Disorders, Healthy Volunteers
12/23
01/24

Download Options